AbbVie ABBV is a leading player in the field of neuroscience, which includes popular drugs…
FDA Advisors Oppose Otsuka’s PTSD Treatment Proposal
FDA Advisory Panel Rejects Efficacy of New PTSD Treatment Combination The U.S. Food and Drug…
drug and pharmaceutical companies
GSK loses £3bn after cancer drug rejection in Ireland
GSK Shares Drop Following FDA Rejection of Key Blood Cancer Drug Shares in GlaxoSmithKline (GSK)…
Gilead Secures Deal to Provide HIV Vaccine to Low-Income Nations
Gilead Sciences and the New Era of HIV Prevention Gilead Sciences, Inc. (NASDAQ: GILD) has…
Pharmaceuticals and Tech Shaping Nigeria’s Universal Health Coverage
Challenges in Achieving Universal Health Coverage The management of the Bayelsa State Health Insurance Scheme…
New Medication Approved by FDA
Thailand’s Initiative to Combat Hepatitis C with Affordable Drug The Government Pharmaceutical Organisation (GPO) in…
BMO Capital Keeps ‘Outperform’ on Alnylam Pharmaceuticals (ALNY), Boosts Price Target
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) is among the best stocks added in a Growth…
Vistagen Aims for Transformative SAD Drug Approval with Q4 2025 PALISADE-3 Data, Bolstering Unique Neuroscience Pipeline
Earnings Call Insights: Vistagen Therapeutics (VTGN) Q4 2025 Management View President and CEO Shawn K….
No More Posts Available.
No more pages to load.